SCIENTISTS have suggested that stem cell therapy may offer a regenerative cure for type 1 diabetes (T1D).They said stem cell therapy could be used to regenerate cells of pancreas that produce insulin, ...

Once-weekly efsitora vs once-daily degludec was associated with comparable glycemic control outcomes and improved patient-reported outcomes.

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

Hybrid closed-loop insulin therapy has shown promise for management of type 1 diabetes during pregnancy; however, its efficacy is unclear.In this multicenter, controlled trial, we randomly assigned ...

The immune response has to be reduced or prevented, so the growth of new beta cells the therapy would induce can survive and create insulin. The full study is available in Science Translational ...

New advancements in stem cell therapy offer hope for insulin independence and improved diabetes management. By Cameron French Jan 28, 2025 11:15 am Photo credit: Shutterstock.com / LightField Studios ...

Scientists have, for the first time, tracked nasal insulin traveling into the brain—revealing why it may work differently in ...

A groundbreaking brain imaging study from Wake Forest University School of Medicine confirms a vital step toward new ...

Women successfully using insulin before conception often benefit from continuing this treatment, potentially adding metformin as a complementary therapy rather than replacing insulin entirely.